Graphene Investments SAS fully divested its entire position in Centene Corporation during Q3 2025, selling approximately 55,600 shares valued at an estimated $3.02 million, which previously constituted 1.9673% of its AUM. This strategic exit follows Centene's stock plummeting 47.35% year-over-year, a significant downgrade in its adjusted earnings guidance from $7.25 to $1.75 per share, and looming uncertainty over the potential expiration of enhanced Affordable Care Act premium tax credits at the end of 2025, which could severely impact its substantial marketplace plan membership.
Graphene Investments SAS fully divested its entire 1.9673% position in Centene Corporation (CNC) during Q3 2025, selling approximately 55,600 shares valued at an estimated $3.02 million. This institutional exit coincides with Centene's significant market underperformance, with its stock priced at $37.64 as of October 6, 2025, reflecting a 47.35% decline year-over-year and a 66.0 percentage point lag against the S&P 500. The company faces severe fundamental headwinds, evidenced by a drastic revision in its adjusted earnings guidance for the current year to approximately $1.75 per share, a substantial reduction from the initial estimate of $7.25 per share. This downward revision underscores significant operational or market challenges impacting profitability. A primary driver of this uncertainty is Centene's considerable exposure to Affordable Care Act (ACA) marketplace plans, which represent 21% of its total membership. The enhanced premium tax credits, instrumental in more than doubling marketplace enrollment to over 24 million, are set to expire at the end of 2025. Their expiration could lead to significant membership attrition and substantial premium increases for consumers, posing a material risk to Centene's future revenue and earnings.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly negative
Sentiment Score
-0.85
Ticker Sentiment
